DBT
NBIX icon

Dubuque Bank & Trust’s Neurocrine Biosciences NBIX Stock Holding History

Dubuque Bank & Trust’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,265
Closed -$111K – 452
2019
Q1 		$111K Hold
1,265
– – 0.02% 199
2018
Q4 		$90K Sell
1,265
-960
-43% -$92K 0.02% 203
2018
Q3 		$274K Buy
+2,225
New +$252K 0.04% 138

Other funds holding NBIX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dubuque Bank & Trust's NBIX Position: Q2 2019 in Review

Dubuque Bank & Trust sold out of Neurocrine Biosciences (NBIX) in Q2 2019, closing a stake of 1,265 shares — an estimated $111K sold.

Dubuque Bank & Trust first reported a position in NBIX in Q3 2018 and held it in 3 quarters. The position peaked at $274K in Q3 2018. 302 funds tracked by Wall St. Rank hold NBIX as of Q2 2019.

  • Dubuque Bank & Trust reported no remaining Neurocrine Biosciences position as of Q2 2019 after selling out during the quarter.
  • Dubuque Bank & Trust sold 1,265 Neurocrine Biosciences shares in Q2 2019, an estimated $111K.
  • Dubuque Bank & Trust first reported a position in Neurocrine Biosciences in Q3 2018 and held it in 3 quarters.
  • Dubuque Bank & Trust's Neurocrine Biosciences position peaked at $274K in Q3 2018.
  • 302 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2019.

Based on Dubuque Bank & Trust's 13F filing for Q2 2019, filed 10 Jul 2019.